World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
103
Citations
40046
World Ranking
7349
National Ranking
415

Uwe Haberkorn publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Uwe Haberkorn sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 575 publications — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Uwe Haberkorn D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Uwe Haberkorn sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 103 D-Index — 65th percentile

65% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2020 - German National Academy of Sciences Leopoldina - Deutsche Akademie der Naturforscher Leopoldina – Nationale Akademie der Wissenschaften Radiology

Overview

Uwe Haberkorn is affiliated with Heidelberg University in Germany. Their research focuses primarily on medicine, with specific emphasis on oncology, radiology, nuclear medicine, and imaging. Haberkorn's work spans several subfields, including pulmonary and respiratory medicine, surgery, and cancer research.

The scientist's research covers a range of topics that include:

  • Peptidase Inhibition and Analysis
  • Protease and Inhibitor Mechanisms
  • Radiopharmaceutical Chemistry and Applications
  • Cardiac Structural Anomalies and Repair
  • Prostate Cancer Treatment and Research
  • Medical Imaging Techniques and Applications
  • Neuropeptides and Animal Physiology

Haberkorn has contributed to several peer-reviewed publications. Significant recent papers include:

  • "E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET" (2021) published in the European Journal of Nuclear Medicine and Molecular Imaging
  • "PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0" (2023) published in the European Journal of Nuclear Medicine and Molecular Imaging
  • "FAPI-74 PET/CT Using Either18F-AlF or Cold-Kit68Ga Labeling: Biodistribution, Radiation Dosimetry, and Tumor Delineation in Lung Cancer Patients" (2020) published in the Journal of Nuclear Medicine
  • "FAPI PET: Fibroblast Activation Protein Inhibitor Use in Oncologic and Nononcologic Disease" (2023) published in Radiology
  • "The Latest Developments in Imaging of Fibroblast Activation Protein" (2020) published in the Journal of Nuclear Medicine

The main publication venues where Haberkorn has frequently contributed are:

  • European Journal of Nuclear Medicine and Molecular Imaging
  • Journal of Nuclear Medicine
  • Nuklearmedizin - NuclearMedicine
  • Radiotherapy and Oncology
  • Cancers

Frequent co-authors in Haberkorn's research include:

  • Frederik L. Giesel
  • Clemens Kratochwil
  • Jürgen Debus
  • Manuel Röhrich
  • Stefan A. Koerber

In 2020, Haberkorn was awarded membership in the German National Academy of Sciences Leopoldina, reflecting recognition within the scientific community related to radiology.

Best Publications

  • 68Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer

    Clemens Kratochwil;Paul Flechsig;Thomas Lindner;Labidi Abderrahim

  • The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer

    Ali Afshar-Oromieh;Eleni Avtzi;Frederik L. Giesel;Tim Holland-Letz

  • Comparison of PET imaging with a 68Ga-labelled PSMA ligand and 18F-choline-based PET/CT for the diagnosis of recurrent prostate cancer

    Ali Afshar-Oromieh;Christian M. Zechmann;Anna Malcher;Matthias Eder

  • PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions.

    A. Afshar-Oromieh;A. Malcher;M. Eder;Michael Eisenhut

  • German Multicenter Study Investigating 177Lu-PSMA-617 Radioligand Therapy in Advanced Prostate Cancer Patients.

    Kambiz Rahbar;Hojjat Ahmadzadehfar;Clemens Kratochwil;Uwe Haberkorn

  • 68Ga-complex lipophilicity and the targeting property of a urea-based PSMA inhibitor for PET imaging

    Matthias Eder;Martin Schäfer;Ulrike Bauder-Wüst;William Edmund Hull

  • Performance Evaluation of a Whole-Body PET Scanner Using the NEMA Protocol

    Gunnar Brix;Joachim Zaers;Lars Eric Adam;Matthias E. Bellemann

  • Remission of Major Depression Under Deep Brain Stimulation of the Lateral Habenula in a Therapy-Refractory Patient

    Alexander Sartorius;Karl L. Kiening;Peter Kirsch;Carl C. von Gall

  • PSMA-Targeted Radionuclide Therapy of Metastatic Castration-Resistant Prostate Cancer with 177Lu-Labeled PSMA-617

    Clemens Kratochwil;Frederik L. Giesel;Melsa Stefanova;Martina Benešová

  • A Tumor-Imaging Method Targeting Cancer-Associated Fibroblasts.

    Anastasia Loktev;Anastasia Loktev;Anastasia Loktev;Thomas Lindner;Walter Mier;Jürgen Debus;Jürgen Debus

  • Preclinical evaluation of a tailor-made DOTA-conjugated PSMA inhibitor with optimized linker moiety for imaging and endoradiotherapy of prostate cancer

    Martina Benešová;Martin Schäfer;Ulrike Bauder-Wüst;Ali Afshar-Oromieh

  • Methylglyoxal modification of Na v 1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy

    Angelika Bierhaus;Thomas Fleming;Stoyan Stoyanov;Andreas Leffler;Andreas Leffler

  • Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients.

    Ali Afshar-Oromieh;Ali Afshar-Oromieh;Tim Holland-Letz;Frederik L. Giesel;Clemens Kratochwil

  • Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein.

    Joerg Petersen;Maura Dandri;Walter Mier;Marc Lütgehetmann

  • Novel Preclinical and Radiopharmaceutical Aspects of [68Ga]Ga-PSMA-HBED-CC: A New PET Tracer for Imaging of Prostate Cancer

    Matthias Eder;Oliver Neels;Miriam Müller;Ulrike Bauder-Wüst

  • Targeted α-Therapy of Metastatic Castration-Resistant Prostate Cancer with 225Ac-PSMA-617: Swimmer-Plot Analysis Suggests Efficacy Regarding Duration of Tumor Control

    Clemens Kratochwil;Frank Bruchertseifer;Hendrik Rathke;Markus Hohenfellner

  • Evaluation of Positron Emission Tomography Imaging Using [68Ga]-DOTA-D Phe1-Tyr3-Octreotide in Comparison to [111In]-DTPAOC SPECT. First Results in Patients with Neuroendocrine Tumors

    Jörg Kowalski;Marcus Henze;Marcus Henze;Jochen Schuhmacher;Helmut R Mäcke

  • The Theranostic PSMA Ligand PSMA-617 in the Diagnosis of Prostate Cancer by PET/CT: Biodistribution in Humans, Radiation Dosimetry, and First Evaluation of Tumor Lesions

    Ali Afshar-Oromieh;Ali Afshar-Oromieh;Henrik Hetzheim;Clemens Kratochwil;Martina Benesova

  • Targeted α-Therapy of Metastatic Castration-Resistant Prostate Cancer with 225Ac-PSMA-617: Dosimetry Estimate and Empiric Dose Finding.

    Clemens Kratochwil;Frank Bruchertseifer;Hendrik Rathke;Marcus Bronzel

  • Comparison of PET/CT and PET/MRI hybrid systems using a 68Ga-labelled PSMA ligand for the diagnosis of recurrent prostate cancer: initial experience.

    A. Afshar-Oromieh;A. Afshar-Oromieh;U. Haberkorn;U. Haberkorn;H. P. Schlemmer;M. Fenchel

Frequent Co-Authors

Walter Mier
Walter Mier University Hospital Heidelberg
Frederik L. Giesel
Frederik L. Giesel University Hospital Heidelberg
Jürgen Debus
Jürgen Debus University Hospital Heidelberg
Heinz-Peter Schlemmer
Heinz-Peter Schlemmer German Cancer Research Center
John W. Babich
John W. Babich Cornell University
Dirk Koczan
Dirk Koczan University of Rostock
Hartmut Goldschmidt
Hartmut Goldschmidt University Hospital Heidelberg
Michael V. Knopp
Michael V. Knopp The Ohio State University Wexner Medical Center
Dirk Jäger
Dirk Jäger Heidelberg University
Christel Herold-Mende
Christel Herold-Mende Heidelberg University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're exploring alternative healthcare careers or flexible education pathways, there are several online degree options worth considering. Some students may find a quicker entry into the healthcare field through entry level msn programs online, which are tailored for non-nurses looking to transition into nursing with an advanced degree.

For those focused on accessibility, the question of what is the easiest nursing school to get into is common. Some nursing programs offer less competitive admissions criteria, making them more reachable for students with varied academic backgrounds.

Outside of clinical roles, many learners are pursuing medical coding and billing classes online with financial aid. These programs offer training for essential behind-the-scenes roles in healthcare administration, often with financial support available.

Lastly, if standardized testing is a concern, there are options such as an lpn program no entrance exam required, making entry into the nursing workforce more accessible for many students.

Best Scientists Citing Uwe Haberkorn

Trending Scientists